Clinical Trials on Relapsed T-Cell Lymphoblastic Lymphoma
Total 9021 results
-
Second Affiliated Hospital, School of Medicine,...Ningbo No. 1 Hospital; Jinhua Central Hospital; Huizhou Municipal Central HospitalRecruiting
-
Shanghai Zhongshan HospitalTakeda; BeiGeneNot yet recruiting
-
Henan Cancer HospitalRecruitingPeripheral T-Cell LymphomaChina
-
Peking UniversityPeking University Cancer Hospital & InstituteNot yet recruitingNK/T Cell LymphomaChina
-
Antengene CorporationRecruitingPeripheral T-cell Lymphoma | NK/T-cell LymphomaChina
-
Genor Biopharma Co., Ltd.RecruitingPeripheral T Cell LymphomaChina
-
Innate PharmaCompletedPeripheral T Cell LymphomaKorea, Republic of, United States
-
University of Colorado, DenverBristol-Myers SquibbActive, not recruitingPeripheral T Cell LymphomaUnited States
-
Innate PharmaCompletedCutaneous T-Cell LymphomaUnited States, France, Netherlands, United Kingdom
-
Conjupro Biotherapeutics, Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Withdrawn
-
Eli Lilly and CompanyCompletedCutaneous T-Cell LymphomaUnited States
-
Nanjing Sanhome Pharmaceutical, Co., Ltd.UnknownPeripheral T Cell Lymphoma
-
Zhejiang Cancer HospitalUnknownPeripheral T Cell LymphomaChina
-
Eisai Co., Ltd.CompletedPeripheral T-Cell LymphomaJapan
-
The University of Hong KongUnknown
-
The First Affiliated Hospital of Soochow UniversityUnknown
-
H. Lee Moffitt Cancer Center and Research InstituteSeagen Inc.TerminatedPilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30Peripheral T-Cell LymphomaUnited States
-
Nanfang Hospital of Southern Medical UniversityUnknownPeripheral T Cell LymphomaChina
-
Kyowa Hakko Kirin Pharma, Inc.CompletedPeripheral T-Cell LymphomaFrance, United Kingdom, Netherlands, Denmark, Italy, Spain
-
Samsung Medical CenterCompleted
-
NovartisCompletedCutaneous T-Cell Lymphoma | TumorsJapan
-
University Hospital, GrenobleFrench Innovative Leukemia OrganisationCompletedPeripheral T Cell LymphomaFrance
-
Mahidol UniversityBayerTerminatedPeripheral T-Cell LymphomaThailand
-
OncoSec Medical IncorporatedTerminatedMycosis Fungoides (MF) | Cutaneous T Cell Lymphomas (CTCL)United States
-
National Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Splenic Marginal Zone Lymphoma | Anaplastic Large Cell Lymphoma | Recurrent Adult Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell... and other conditionsUnited States, Italy
-
Tessa TherapeuticsActive, not recruitingAnaplastic Large Cell Lymphoma | Diffuse Large B Cell Lymphoma | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Primary Mediastinal Large B-Cell Lymphoma (PMBCL)United States
-
Bio-Path Holdings, Inc.RecruitingFollicular Lymphoma | Hodgkin Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | DLBCL | Cutaneous T-cell Lymphoma (CTCL) | Peripheral T-cell Lymphoma (PTCL)United States
-
University of Texas Southwestern Medical CenterWithdrawnCutaneous T-Cell LymphomasUnited States
-
Centre Henri BecquerelNot yet recruitingPeripheral T Cell LymphomaFrance
-
Henan Cancer HospitalRecruiting
-
Peking UniversityRecruitingPeripheral T Cell LymphomaChina
-
Sun Yat-sen UniversityRecruitingNK/T Cell Lymphoma NosChina
-
Rhizen Pharmaceuticals SAWithdrawnPeripheral T Cell LymphomaUnited States
-
University of BirminghamCelgene; Amgen; BloodwiseCompletedPeripheral T Cell LymphomaUnited Kingdom
-
National Cancer Centre, SingaporeBristol-Myers SquibbWithdrawnNK/T Cell LymphomaSingapore
-
Mingzhi ZhangUnknownNK/T-Cell LymphomaChina
-
Mingzhi ZhangUnknownNK/T Cell LymphomaChina
-
Ruijin HospitalUnknownPeripheral T Cell LymphomaChina
-
Adam LernerNovartisTerminated
-
Janssen Research & Development, LLCCompletedLymphoma, T-Cell, CutaneousFrance, United Kingdom, Spain, Portugal, United States, Germany
-
Guangdong Provincial People's HospitalUnknown
-
M.D. Anderson Cancer CenterGalderma R&DCompleted
-
The Lymphoma Academic Research OrganisationCompletedPeripheral T Cell LymphomaFrance
-
Eisai Inc.WithdrawnPeripheral T-Cell LymphomaUnited States
-
University of GöttingenCompletedPeripheral T-Cell Lymphoma
-
Chonnam National University HospitalKyungpook National University HospitalUnknownPeripheral T Cell LymphomaKorea, Republic of
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma and other conditionsUnited States
-
University of California, San FranciscoTerminatedAcute Myeloid Leukemia | Multiple Myeloma | Hodgkin Disease | Lymphoma, Mantle-Cell | Acute Lymphoblastic Leukemia | Lymphoma, T-Cell, Peripheral | Chronic Myelogenous Leukemia | Myelodysplasia | Lymphoma, Large-Cell, Diffuse | T-NK Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterLeudositeTerminatedLymphoma, B-Cell | Lymphoma, T-Cell | Lymphoma, Low-Grade | Leukemia, Lymphocytic, Acute | Leukemia, Lymphocytic, ChronicUnited States